Zydus receives final approvals from USFDA for skin ointment, heart medicine
The group also received a final nod for Amlodipine and Atorvastatin Tablets USP that is administered for heart and cholesterol-related cases.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Atorvastatin Calcium | Biotechnology | Cardiology | Cholesterol | Heart | Lipitor | Norvasc | Pharmaceuticals | Skin | Statin Therapy | Zivast